791-795
REVIEW
Azathioprine prescribing in neurology
P. Goldsmith, G. Lennox and N. Bhalla
796-802
ORIGINAL COMMUNICATION
Stroke due to atrial fibrillation and the attitude to prescribing anticoagulant prevention in Italy.
A prospective study of a consecutive stroke population admitted to a comprehensive stroke unit
C. Gandolfo, M. Balestrino, A. Burrone, M. Del Sette and C. Finocchi
803-806
ORIGINAL COMMUNICATION
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)
Novel compound heterozygous mutations in the SACS gene
S. Kamada, S. Okawa, T. Imota, M. Sugawara and I. Toyoshima
807-812
ORIGINAL COMMUNICATION
Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache
F. Bono, D. Messina, C. Giliberto, D. Cristiano and G. Broussard, et al.
813-819
ORIGINAL COMMUNICATION
Increased severity over generations of Charcot-Marie-Tooth disease type 1A
I. Steiner, M. Gotkine, B. Steiner-Birmanns, I. Biran and S. Silverstein, et al.
820-827
ORIGINAL COMMUNICATION
Rehabilitation in primary and metastatic brain tumours
Impact of functional outcomes on survival
V. Tang, M. Rathbone, J. Park Dorsay, S. Jiang and D. Harvey
828-830
ORIGINAL COMMUNICATION
Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment
M. C. J. Hanse, M. B. van’t Veer, K. van Lom and M. J. van den Bent
831-838
ORIGINAL COMMUNICATION
Identification of eight novel mutations of the acid α-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II
L. Wan, C.-C. Lee, C.-M. Hsu, W.-L. Hwu and C.-C. Yang, et al.
839-842
ORIGINAL COMMUNICATION
Cerebrotendinous xanthomatosis: Neuropathological findings
B. Pilo de la Fuente, I. Ruiz, A. Lopez de Munain and A. Jimenez-Escrig
843-847
ORIGINAL COMMUNICATION
Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A
D. Tiple, S. Strano, C. Colosimo, G. Fabbrini and G. Calcagnini, et al.
848-852
ORIGINAL COMMUNICATION
Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients
R. H. B. Benedict, F. Munschauer, P. Zarevics, D. Erlanger and V. Rowe, et al.
853-857
ORIGINAL COMMUNICATION
Highly skewed inactivation of the wild-type X-chromosome in asymptomatic female carriers of spinal and bulbar muscular atrophy (Kennedy’s disease)
C. Paradas, F. Solano, F. Carrillo, C. Fernández and J. Bautista, et al.
858-866
ORIGINAL COMMUNICATION
Evaluating the efficacy of acupuncture in defined aspects of stroke recovery
A randomised, placebo controlled single blind study
V. Hopwood, G. Lewith, P. Prescott and M. J. Campbell
867-874
ORIGINAL COMMUNICATION
What should be defined as good outcome in stroke trials; a modified Rankin score of 0–1 or 0–2?
N. Weisscher, M. Vermeulen, Y. B. Roos and R. J. de Haan
875-880
ORIGINAL COMMUNICATION
Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke
M. Uyttenboogaart, M. W. Koch, K. Koopman, P. C. Vroomen and G. J. Luijckx, et al.
881-884
ORIGINAL COMMUNICATION
Deep brain stimulation for dystonia: outcome at long-term follow-up
T. J. Loher, H.-H. Capelle, A. Kaelin-Lang, S. Weber and R. Weigel, et al.
885-890
ORIGINAL COMMUNICATION
Pituitary stalk duplication in association with moya moya disease and bilateral morning glory disc anomaly – broadening the clinical spectrum of midline defects
T. Loddenkemper, N. R. Friedman, P. M. Ruggieri, A. Marcotty and J. Sears, et al.
891-895
ORIGINAL COMMUNICATION
Growth rate of non-operated meningiomas
L. A. Zeidman, W. J. Ankenbrandt, Hongyan Du, N. Paleologos and N. A. Vick
896-902
ORIGINAL COMMUNICATION
Accuracy of perfusion-CT inpredicting malignant middle cerebral artery brain infarction
R. Dittrich, S. P. Kloska, T. Fischer, E. Nam and M. A. Ritter, et al.
903-909
ORIGINAL COMMUNICATION
Interpretation of electrodiagnostic findings in sporadic progressive muscular atrophy
J. Visser, M. de Visser, R. M. Van den Berg-Vos, L. H. Van den Berg and J. H. J. Wokke, et al.
910-916
ORIGINAL COMMUNICATION
The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis
T. A. M. Siepman, A. C. J. W. Janssens, I. de Koning, C. H. Polman and J. B. Boringa, et al.
917-924
ORIGINAL COMMUNICATION
Intrathecal anti-αB-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barré syndrome
Julia Wanschitz*, Rainer Ehling*, Wolfgang N. Löscher, Betinna Künz and Florian Deisenhammer, et al.
925-926
LETTER TO THE EDITORS
Neuro-Whipple confirmed five years after a presumptive diagnosis of a primitive CNS vasculitis
J. El Helou, G. Saliba, I. Kolev and C. Pierrot-Deseilligny
927-928
LETTER TO THE EDITORS
Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype
J. Haberlová, K. G. Claeys, J. Zámečník, P. De Jonghe and P. Seeman
929-931
LETTER TO THE EDITORS
Calcineurin inhibitormediated bilateral hippocampal injury after bone marrow transplantation
S.-H. Lee, B.-C. Kim, D.-H. Yang, M.-S. Park and S.-M. Choi, et al.
932-933
LETTER TO THE EDITORS
Intracerebral hemorrhage associated with sildenafil use: a case report
M. H. Alpsan, N. Bebek, F. D. Ciftci, O. Coban and S. Bahar, et al.
934-935
LETTER TO THE EDITORS
An adult case of cyclic vomiting syndrome successfully responding to valproic acid
Y. Nakazato, N. Tamura and K. Shimazu
936-938
LETTER TO THE EDITORS
Electrophysiological predictors of steroidresponsiveness in chronic inflammatory demyelinating polyneuropathy
Y. A. Rajabally, M. Narasimhan and G. Chavada
939-941
LETTER TO THE EDITORS
Diagnosis of cerebral toxoplasmosis by detection of Toxoplasma gondii tachyzoites in cerebrospinal fluid
C. Palm, H. Tumani, T. Pietzcker and D. Bengel
942-943
LETTER TO THE EDITORS
Botulinum toxin in a taskspecific oromandibular dystonia in a bingo caller
M. Díaz-Sánchez and J. C. Martínez-Castrillo
944-945
LETTER TO THE EDITORS
Brain hemorrhage as a complication of chronic hepatitis C virus-related vasculitis
M. E. Erro Aguirre, T. Ayuso Blanco, T. Tuñón Àlvarez and M. Herrera Isasi
946-947
PIONEERS IN NEUROLOGY
John Carew Eccles (1903–1997)
D. Todman
948-950
JOURNAL CLUB
News on neurological treatment II
Michael Strupp
951-952
COMMUNICATIONS
Communications of the European Neurological Society